- Research article
- Open Access
Evolutionary relationships of Aurora kinases: Implications for model organism studies and the development of anti-cancer drugs
© Brown et al; licensee BioMed Central Ltd. 2004
- Received: 12 May 2004
- Accepted: 12 October 2004
- Published: 12 October 2004
As key regulators of mitotic chromosome segregation, the Aurora family of serine/threonine kinases play an important role in cell division. Abnormalities in Aurora kinases have been strongly linked with cancer, which has lead to the recent development of new classes of anti-cancer drugs that specifically target the ATP-binding domain of these kinases. From an evolutionary perspective, the species distribution of the Aurora kinase family is complex. Mammals uniquely have three Aurora kinases, Aurora-A, Aurora-B, and Aurora-C, while for other metazoans, including the frog, fruitfly and nematode, only Aurora-A and Aurora-B kinases are known. The fungi have a single Aurora-like homolog. Based on the tacit assumption of orthology to human counterparts, model organism studies have been central to the functional characterization of Aurora kinases. However, the ortholog and paralog relationships of these kinases across various species have not been rigorously examined. Here, we present comprehensive evolutionary analyses of the Aurora kinase family.
Phylogenetic trees suggest that all three vertebrate Auroras evolved from a single urochordate ancestor. Specifically, Aurora-A is an orthologous lineage in cold-blooded vertebrates and mammals, while structurally similar Aurora-B and Aurora-C evolved more recently in mammals from a duplication of an ancestral Aurora-B/C gene found in cold-blooded vertebrates. All so-called Aurora-A and Aurora-B kinases of non-chordates are ancestral to the clade of chordate Auroras and, therefore, are not strictly orthologous to vertebrate counterparts. Comparisons of human Aurora-B and Aurora-C sequences to the resolved 3D structure of human Aurora-A lends further support to the evolutionary scenario that vertebrate Aurora-B and Aurora-C are closely related paralogs. Of the 26 residues lining the ATP-binding active site, only three were variant and all were specific to Aurora-A.
In this study, we found that invertebrate Aurora-A and Aurora-B kinases are highly divergent protein families from their chordate counterparts. Furthermore, while the Aurora-A family is ubiquitous among all vertebrates, the Aurora-B and Aurora-C families in humans arose from a gene duplication event in mammals. These findings show the importance of understanding evolutionary relationships in the interpretation and transference of knowledge from studies of model organism systems to human cellular biology. In addition, given the important role of Aurora kinases in cancer, evolutionary analysis and comparisons of ATP-binding domains suggest a rationale for designing dual action anti-tumor drugs that inhibit both Aurora-B and Aurora-C kinases.
- Aurora Kinase
- Nonredundant Protein Database
- Model Organism Study
- Aurora Kinase Family
- PLK4 Kinase
The Auroras are a conserved family of serine/threonine kinases which have essential functions in cell division [1, 2]. In mitosis, Aurora kinases are required for chromosome segregation, condensation and orientation in the metaphase plate, spindle assembly, and the completion of cytokinesis.
Model organism studies have played a pivotal role in functional characterization of Aurora kinases. Aurora kinases were first identified as mutant alleles in Drosophila melanogaster (fruitfly) that caused defective spindle-pole formation . Subsequently, Drosophila was found to have a second Aurora homolog , and the nematode, Caenorhabditis elegans, similarly has two Aurora-like genes [5, 6]. The fungi, Saccharomyces cerevisiae and Schizosaccharomyces pombe, have a single Aurora, known as increase-in-ploidy 1 (Ipl1)  and Aurora-related kinase 1 (Ark1) , respectively. Among cold-blooded vertebrates, Aurora kinases have been most widely studied in the frog, Xenopus laevis, which has two kinases; Aurora-A and Aurora-B [9, 10]. More recently discovered is a third Aurora kinase called Aurora-C in rodents and humans .
The Aurora kinases are mitotic kinases that generally associate with chromosomes, often in complexes with other proteins, and interact with cytoskeletal components in cell division. The three mammalian Aurora kinases appear at specific locations during mitosis. Aurora-A, the "polar kinase", primarily associates with the separating centrosomes while Aurora-B, the "equatorial kinase", is a chromosomal passenger protein . The least studied Aurora kinase, Aurora-C, appears to be localized to the centrosome from anaphase to telophase and is highly expressed in the testis [11, 12].
Recent studies indicate that all three Aurora kinases have strong associations with cancer. Aurora-A has been mapped to a region in the human chromosome (20q13.2-13.3) that is amplified in cancer cell lines and primary tumors [13, 14]. Transfected mouse cell lines with Aurora-A have been shown to cause tumors when injected into nude mice [14, 15] and a polymorphic variant (amino acid substitution Phe31Ile) has been associated with human colon tumors . Expression levels of Aurora-B  and Aurora-C  were elevated in several cancer cell lines relative to normal fibroblasts. Aurora-C is located on chromosome 19q13.2 to 13.4, a region associated with loss of heterozygosity in ovarian cancer  and pancreatic carcinomas . Thus, the inhibition of one or more Aurora kinases might be a novel chemotherapeutic strategy against cancer . Recently, several reports by research groups in pharmaceutical and biotechnology companies describe small molecules that target the ATP-binding domain of Aurora kinases, and have effects in human tumor cell lines [21–23].
Despite the importance of model organisms in understanding Aurora kinase function, the evolutionary relationships among these variants are unclear. Two previous phylogenetic analyses of Aurora kinases were incomplete because the contemporary complement of Aurora kinases was unavailable  or certain family members, namely the Aurora-C kinases, were excluded . Here, we present an evolutionary analysis of all known Aurora kinases. We show that vertebrate Aurora kinases evolved through a series of gene duplication events from a chordate ancestor, and that they are highly distinct from invertebrate homologs. Moreover, the recent divergence, thus high level of sequence similarity, of human Aurora-B and Aurora-C suggests a novel anti-cancer strategy which might simultaneously target the ATP-binding domains of this kinase pair with dual action inhibitors.
Aurora Evolution in Chordates
In order to construct a comprehensive phylogenetic tree, GenBank was searched for all possible Aurora kinases. In addition to previously published Aurora kinase sequences, further chordate and urochordate Aurora homologs were found by using mammalian Aurora-A, Aurora-B and Aurora-C protein sequences as queries in BLASTP or TBLASTN  searches of the genomes of the pufferfish, Takifugu rubripes , the zebrafish, Danio rerio , and the ascidian, Ciona intestinalis .
Among true vertebrates, our phylogenetic tree shows that the Aurora kinases underwent two major gene duplication events. The first split in cold-blooded vertebrates lead to the formation of two Aurora subfamilies. One branch encompasses all known vertebrate Aurora-A sequences in a single orthologous lineage that includes fishes, amphibians and mammals. This family includes previously identified Aurora-A kinases in Xenopus laevis, rodents and humans as well as a new putative ortholog in T. rubripes.
The second family, previously known as Aurora-B [2, 28] consists of cold-blooded vertebrate and mammalian Aurora-B as well as mammalian Aurora-C. Mammalian Aurora-B and Aurora-C are similarly related to the cold-blooded vertebrate Aurora presently known as "Aurora-B" in amphibians (X. laevis) and fish (D. rerio and T. rubripes). Searches of T. rubripes and D. rerio protein and DNA sequence databases detected several other putative serine/threonine kinase homologs but none were Auroras according to phylogenetic analyses. Thus, cold-blooded vertebrates appear to have only a single Aurora-A ortholog, a single Aurora-B-like homolog, and lack an Aurora-C ortholog. Conversely, Aurora-A, Aurora-B and Aurora-C appear to be ubiquitous to mammals (at least placentals) where they are encoded by separate chromosomal loci. It would appear that mammalian Aurora-B and Aurora-C evolved from a duplication event involving the ancestral Aurora-B found in cold-blooded vertebrates. This depiction of the evolutionary relationships of vertebrate Auroras was consistently determined by four different phylogenetic methods with high bootstrap or Bayesian posterior probability values (Fig. 2).
The Aurora kinases of plants and invertebrates are all outgroup lineages to chordates / urochordates (Fig. 2). Although all phylogenetic methods strongly support the monophyly of chordate Aurora kinases, the exact ordering among nodes leading to the various plant and invertebrate clusters were not resolved with similarly high bootstrap or probability values. Placement of plant Aurora kinases between chordates and invertebrates might be an artifact of tree construction methods. (Plant, protist, fungal and invertebrate lineages were all highly diverged from vertebrate Aurora kinases as witnessed by their longer branch lengths.) The earliest lineages of the Aurora tree are those fungal model organisms with a single Aurora-like homolog S. cerevisiae (Ipl1) and S. pombe (Ark1). Other basal branches are the amitochondrial fungi, Encephalitozoon cuniculi, and the kinetoplast protist, Leishmania major .
Model Organisms in Context
Aurora-B and Aurora-C, as specific innovations in mammals, might have distinct protein-binding partners and cellular functions from those of Aurora-B kinases in amphibians. The perturbation of Aurora-B function in different systems suggests variable kinetochore-microtubule interactions . Transfection of normal rat kidney cells with a kinase-inactive, dominant negative form of Aurora-B caused multiple defects in mitosis  while an Aurora-B kinase inactivating antibody seemed to have milder effects in Xenopus tissue culture cells . Xenopus Aurora-A functions in the extrusion of the first polar body  while in C. elegans Aurora B plays a similar role . Also, C. elegans Aurora-B binds to a protein CSC-1 which has no homolog in other studied systems . While these studies used different experimental methods, the lack of direct orthology among vertebrate and invertebrate Aurora-A and Aurora-B might also account for functional differences in these systems.
The evolutionary analysis presented here also suggests revisiting the present Aurora nomenclature. Adams et al.  proposed a naming scheme where, irrespective of species, the original Aurora is known as Aurora-A (also called AIRK1, Aurora, Aurora-2, AIK, BTAK, human STK15, mouse STK6 and others), followed by Aurora-B (also known as AIRK-2, IAL, Aurora-1, AIK2, STK12 and others) and Aurora-C (or STK13). However, the proposed nomenclature fails to reflect evolutionary, and possibly functional, relationships among the Auroras. We suggest that Aurora-A be retained as the name for all orthologs in mammals and cold-blooded vertebrates. While Aurora-B and Aurora-C seem appropriate for mammalian versions, the ancestral cold-blooded vertebrate "Aurora-B" might be renamed "Aurora-BC". As for invertebrates, the so-called Aurora-A or Aurora-B genes are clearly not orthologs to their respective vertebrate counterparts. However, introducing a new nomenclature here might simply add further confusion to the field.
Evolution of an Anti-Cancer Target
There have been several recent reports of Aurora kinase inhibitors that are under development by pharmaceutical or biotechnology companies for cancer treatment. The compounds Hesperadin (Boehringer Ingelheim ) and ZM447439 (AstraZeneca ) are suggested to be targeted to Aurora-B. While both studies show lesser levels of compound inhibition of Aurora-A as well as several other kinases, neither report included Aurora-C in their kinase profile. Selective inactivation of multiple kinases is not an undesirable pharmaceutical profile for a small molecule inhibitor and, in fact, could be the best strategy to achieve maximal clinical efficacy of an anti-cancer agent . Indeed, an intense area of anti-cancer research is the development of small molecular ATP analogues that generally target the kinase domain of protein kinases . For example, Gleevec (also known as imatinib and made by Novartis) for chronic myelogenous leukemia, is a small-molecule inhibitor that targets BCR-ABL, c-Kit and platelet-derived growth factor receptor kinases . Recently, a selective inhibitor of all three Aurora kinases, VX-680 (made by Vertex Pharmaceuticals), was reported to inhibit cell-cycle progression and induce apoptosis in various human tumor cell types and in vivo xenograft models . Interestingly, although VX-680 is a potent inhibitor of all three Aurora kinases, its apparent inhibition constant is much lower for Aurora-A (0.6 nM) than for either Aurora-B (18 nM) or Aurora-C (4.6 nM). Again, the compound's greater affinity for Aurora-A, relative to Aurora-B and Aurora-C is compatible with the proposed evolutionary scenario of mammalian Auroras.
Evolutionary analysis shows that cell division Aurora kinases, while consistent in theme throughout eukaryotes, have undergone lineage-specific expansions and specialization in metazoans. Aurora-C is the least known of the Aurora kinases. Yet as an evolutionary innovation in mammals, further studies are very much warranted from the perspectives of better understanding its potential roles in both cell replication and tumor progression. A better functional understanding of Aurora-C would help clarify the evolutionary relationships of Aurora-B and Aurora-C in mammals relative to the ancestral Aurora-BC in cold-blooded vertebrates. Additionally, the close evolutionary and structural relationships between mammalian Aurora-B and Aurora-C offers the tantalizing opportunity to design dual kinase inhibitors that might circumvent potential tumor cell resistance to mono-target chemotherapeutics.
All Aurora kinase orthologs and paralogs were initially collected from GenBank nonredundant protein database by performing separate searches using BLASTP  with human Aurora-A, Aurora-B and Aurora-C proteins as query sequences and a cut-off E-value of 1.0e-10. Since this dataset included additional kinases to the Auroras, preliminary multiple sequence alignments and phylogenetic analysis using program CLUSTALW v1.7  served to identify the clade of all known Aurora kinases. Takifugu rubripes, Danio rerios and Ciona intestinalis homologs were obtained by BLASTP and TBLASTN  of species-specific protein and DNA sequence databases, respectively. The top five homologs from each species retrieved from separate searches with human Aurora-A, Aurora-B and Aurora-C were entered into a preliminary phylogenetic analysis using all retrieved Aurora kinases from Genbank. These analyses revealed that T. rubripes and D. rerios had orthologs to X. laevis Aurora-A and Aurora-B but not mammalian Aurora-C. C. intestinalis had a single Aurora-like kinase.
Phylogenetic and structure analysis
PLK4 kinases were selected as the outgroup for phylogenetic analyses because they were the most similar non-Aurora kinases to either human Aurora-A, Aurora-B or Aurora-C in multiple BLASTP  searches of the non-redundant protein database of GenBank. Using alternative kinases as outgroups made no difference to the topology of the Aurora clade. Initial multiple sequence alignments were performed using the program CLUSTALW v1.7  with default settings and subsequently, refined manually using the program SEQLAB of the GCG Wisconsin Package v11.0 software package (Accelrys, San Diego, CA, USA). We removed regions with residues that could not be unambiguously aligned or that contained insertions or deletions. The final multiple sequence alignment was 240 amino acids in length. Pairwise comparisons for the proportion of similar residues were estimated from the length of the shortest sequence without gaps and the Blosum62 weighting matrix as implemented in the program OLDDISTANCES in GCG.
We constructed phylogenetic trees using distance neighbor-joining (NJ), maximum parsimony (MP), maximum likelihood quartet puzzling (QP), and Bayesian posterior probabilities (BP). NJ trees were based on pair wise distances between amino acid sequences using the programs NEIGHBOR and PROTDIST (Dayhoff option) of the PHYLIP 3.6 package . The programs SEQBOOT and CONSENSE were used to estimate the confidence limits of branching points from 1000 bootstrap replications. ML tree topologies were constructed using the software PUZZLE 4.0 , employing 1000 puzzling steps, the JTT substitution matrix, estimation of rate heterogeneity using the gamma distribution model with eight rate categories, and the gamma-parameter estimation from the dataset. MP analysis was performed using PAUP4.0b5 software  where the number and lengths of minimal trees were estimated from 100 random sequence additions, while confidence limits of branch points were estimated by 1000 bootstrap replications. BP trees were constructed using the software MrBayes v3.0B4 [45, 46]. Bayesian analysis used the mixed model of sequence evolution with random starting trees. Markov chains were run for 106 generations, burn-in values were set for 104 generations, and trees sampled every 100 generations. All trees were visualized using the program TREEVIEW v1.6.6 .
For the Aurora kinase phylogeny rooted with PLK4 kinases shown in Fig. 2, the log likelihood of the final ML tree was -8059.78. Four minimal length MP trees were recovered, 1522 steps in length with a consistency index (CI) of 0.5802 and a retention index (RI) of 0.6016. The variable branch arrangements were terminal nodes (human, pig and cow Aurora-B) which did not affect the central findings.
For the unrooted phylogeny of Aurora kinases of model organisms shown in Fig. 3, the log likelihood of the final ML tree was -4469.20. A single minimal length MP trees were recovered, 779 steps in length with a consistency index (CI) of 0.7214 and a retention index (RI) of 0.2786.
The SwissPDBviewer program  was used to obtain the surface representation of human Aurora-A kinase (PDB ID 1muoA). The active site residues, defined as being within 5A of the ADP cofactor, were identified using the program CAST . The multiple sequence alignment for the three human Aurora kinase proteins was obtained using CLUSTALW . Multiple sequence alignment and sequence GenBank accession numbers are available as Supplementary Information [see additional file 1 and 2].
This work was supported by Bioinformatics, Genetics Research, and the Microbial, Musculoskeletal and Proliferative Disease Center for Excellence in Drug Discovery, GlaxoSmithKline.
- Carmena M, Earnshaw WC: The cellular geography of aurora kinases. Nat Rev Mol Cell Biol. 2003, 4: 842-854. 10.1038/nrm1245.View ArticlePubMedGoogle Scholar
- Nigg EA: Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol. 2001, 2: 21-32. 10.1038/35048096.View ArticlePubMedGoogle Scholar
- Glover DM, Leibowitz MH, McLean DA, Parry H: Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell. 1995, 81: 95-105. 10.1016/0092-8674(95)90374-7.View ArticlePubMedGoogle Scholar
- Reich A, Yanai A, Mesilaty-Gross S, Chen-Moses A, Wides R, Motro B: Cloning, mapping, and expression of ial, a novel Drosophila member of the Ipl1/aurora mitotic control kinase family. DNA Cell Biol. 1999, 18: 593-603. 10.1089/104454999315141.View ArticlePubMedGoogle Scholar
- Schumacher JM, Golden A, Donovan PJ: AIR-2: An Aurora/Ipl1-related protein kinase associated with chromosomes and midbody microtubules is required for polar body extrusion and cytokinesis in Caenorhabditis elegans embryos. J Cell Biol. 1998, 143: 1635-1646. 10.1083/jcb.143.6.1635.PubMed CentralView ArticlePubMedGoogle Scholar
- Schumacher JM, Ashcroft N, Donovan PJ, Golden A: A highly conserved centrosomal kinase, AIR-1, is required for accurate cell cycle progression and segregation of developmental factors in Caenorhabditis elegans embryos. Development. 1998, 125: 4391-4402.PubMedGoogle Scholar
- Francisco L, Wang W, Chan CS: Type 1 protein phosphatase acts in opposition to IpL1 protein kinase in regulating yeast chromosome segregation. Mol Cell Biol. 1994, 14: 4731-4740.PubMed CentralView ArticlePubMedGoogle Scholar
- Petersen J, Paris J, Willer M, Philippe M, Hagan IM: The S. pombe aurora-related kinase Ark1 associates with mitotic structures in a stage dependent manner and is required for chromosome segregation. J Cell Sci. 2001, 114: 4371-4384.PubMedGoogle Scholar
- Roghi C, Giet R, Uzbekov R, Morin N, Chartrain I, Le Guellec R, Couturier A, Doree M, Philippe M, Prigent C: The Xenopus protein kinase pEg2 associates with the centrosome in a cell cycle-dependent manner, binds to the spindle microtubules and is involved in bipolar mitotic spindle assembly. J Cell Sci. 1998, 111 (Pt 5): 557-572.Google Scholar
- Adams RR, Wheatley SP, Gouldsworthy AM, Kandels-Lewis SE, Carmena M, Smythe C, Gerloff DL, Earnshaw WC: INCENP binds the Aurora-related kinase AIRK2 and is required to target it to chromosomes, the central spindle and cleavage furrow. Curr Biol. 2000, 10: 1075-1078. 10.1016/S0960-9822(00)00673-4.View ArticlePubMedGoogle Scholar
- Bernard M, Sanseau P, Henry C, Couturier A, Prigent C: Cloning of STK13, a third human protein kinase related to Drosophila aurora and budding yeast Ipl1 that maps on chromosome 19q13.3-ter. Genomics. 1998, 53: 406-409. 10.1006/geno.1998.5522.View ArticlePubMedGoogle Scholar
- Kimura M, Matsuda Y, Yoshioka T, Okano Y: Cell cycle-dependent expression and centrosome localization of a third human aurora/Ipl1-related protein kinase, AIK3. J Biol Chem. 1999, 274: 7334-7340. 10.1074/jbc.274.11.7334.View ArticlePubMedGoogle Scholar
- Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, Chan CS, Novotny M, Slamon DJ, Plowman GD: A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 1998, 17: 3052-3065. 10.1093/emboj/17.11.3052.PubMed CentralView ArticlePubMedGoogle Scholar
- Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S: Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998, 20: 189-193. 10.1038/2496.View ArticlePubMedGoogle Scholar
- Littlepage LE, Wu H, Andresson T, Deanehan JK, Amundadottir LT, Ruderman JV: Identification of phosphorylated residues that affect the activity of the mitotic kinase Aurora-A. Proc Natl Acad Sci U S A. 2002, 99: 15440-15445. 10.1073/pnas.202606599.PubMed CentralView ArticlePubMedGoogle Scholar
- Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J, Chan F, MacCarthy-Morrogh L, Ponder BA, Nagase H, Burn J, Ball S, Almeida M, Linardopoulos S, Balmain A: Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet. 2003, 34: 403-412. 10.1038/ng1220.View ArticlePubMedGoogle Scholar
- Ota T, Suto S, Katayama H, Han ZB, Suzuki F, Maeda M, Tanino M, Terada Y, Tatsuka M: Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. Cancer Res. 2002, 62: 5168-5177.PubMedGoogle Scholar
- Bicher A, Ault K, Kimmelman A, Gershenson D, Reed E, Liang B: Loss of heterozygosity in human ovarian cancer on chromosome 19q. Gynecol Oncol. 1997, 66: 36-40. 10.1006/gyno.1997.4709.View ArticlePubMedGoogle Scholar
- Hoglund M, Gorunova L, Andren-Sandberg A, Dawiskiba S, Mitelman F, Johansson B: Cytogenetic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas: frequent loss of 19p13.3 and gain of 19q13.1-13.2. Genes Chromosomes Cancer. 1998, 21: 8-16. 10.1002/(SICI)1098-2264(199801)21:1<8::AID-GCC3>3.3.CO;2-L.View ArticlePubMedGoogle Scholar
- Mahadevan D, Bearss DJ, Vankayalapati H: Structure-based design of novel anti-cancer agents targeting aurora kinases. Curr Med Chem Anti -Canc Agents. 2003, 3: 25-34.View ArticleGoogle Scholar
- Hauf S, Cole RW, LaTerra S, Zimmer C, Schnapp G, Walter R, Heckel A, van Meel J, Rieder CL, Peters JM: The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J Cell Biol. 2003, 161: 281-294. 10.1083/jcb.200208092.PubMed CentralView ArticlePubMedGoogle Scholar
- Ditchfield C, Johnson VL, Tighe A, Ellston R, Haworth C, Johnson T, Mortlock A, Keen N, Taylor SS: Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J Cell Biol. 2003, 161: 267-280. 10.1083/jcb.200208091.PubMed CentralView ArticlePubMedGoogle Scholar
- Harrington EA, Bebbington D, Moore J, Rasmussen RK, Ajose-Adeogun AO, Nakayama T, Graham JA, Demur C, Hercend T, Diu-Hercend A, Su M, Golec JM, Miller KM: VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat Med. 2004, 10: 262-267. 10.1038/nm1003.View ArticlePubMedGoogle Scholar
- Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25: 3389-3402. 10.1093/nar/25.17.3389.PubMed CentralView ArticlePubMedGoogle Scholar
- Aparicio S, Chapman J, Stupka E, Putnam N, Chia JM, Dehal P, Christoffels A, Rash S, Hoon S, Smit A, Gelpke MD, Roach J, Oh T, Ho IY, Wong M, Detter C, Verhoef F, Predki P, Tay A, Lucas S, Richardson P, Smith SF, Clark MS, Edwards YJ, Doggett N, Zharkikh A, Tavtigian SV, Pruss D, Barnstead M, Evans C, Baden H, Powell J, Glusman G, Rowen L, Hood L, Tan YH, Elgar G, Hawkins T, Venkatesh B, Rokhsar D, Brenner S: Whole-genome shotgun assembly and analysis of the genome of Fugu rubripes. Science. 2002, 297: 1301-1310. 10.1126/science.1072104.View ArticlePubMedGoogle Scholar
- Centre The Sanger Sequencing: The Danio rerio Sequencing Project. 2004Google Scholar
- Dehal P, Satou Y, Campbell RK, Chapman J, Degnan B, De Tomaso A, Davidson B, Di Gregorio A, Gelpke M, Goodstein DM, Harafuji N, Hastings KE, Ho I, Hotta K, Huang W, Kawashima T, Lemaire P, Martinez D, Meinertzhagen IA, Necula S, Nonaka M, Putnam N, Rash S, Saiga H, Satake M, Terry A, Yamada L, Wang HG, Awazu S, Azumi K, Boore J, Branno M, Chin-Bow S, DeSantis R, Doyle S, Francino P, Keys DN, Haga S, Hayashi H, Hino K, Imai KS, Inaba K, Kano S, Kobayashi K, Kobayashi M, Lee BI, Makabe KW, Manohar C, Matassi G, Medina M, Mochizuki Y, Mount S, Morishita T, Miura S, Nakayama A, Nishizaka S, Nomoto H, Ohta F, Oishi K, Rigoutsos I, Sano M, Sasaki A, Sasakura Y, Shoguchi E, T Shin-i, Spagnuolo A, Stainier D, Suzuki MM, Tassy O, Takatori N, Tokuoka M, Yagi K, Yoshizaki F, Wada S, Zhang C, Hyatt PD, Larimer F, Detter C, Doggett N, Glavina T, Hawkins T, Richardson P, Lucas S, Kohara Y, Levine M, Satoh N, Rokhsar DS: The draft genome of Ciona intestinalis: insights into chordate and vertebrate origins. Science. 2002, 298: 2157-2167. 10.1126/science.1080049.View ArticlePubMedGoogle Scholar
- Adams Richard R., Carmena Mar, Earnshaw William C.: Chromosomal passengers and the (aurora) ABCs of mitosis. Trends in Cell Biology. 2001, 11: 49-54. 10.1016/S0962-8924(00)01880-8.View ArticlePubMedGoogle Scholar
- Cheetham GM, Knegtel RM, Coll JT, Renwick SB, Swenson L, Weber P, Lippke JA, Austen DA: Crystal structure of aurora-2, an oncogenic serine/threonine kinase. J Biol Chem. 2002, 277: 42419-42422. 10.1074/jbc.C200426200.View ArticlePubMedGoogle Scholar
- Castro A, Vigneron S, Bernis C, Labbe JC, Prigent C, Lorca T: The D-Box-activating domain (DAD) is a new proteolysis signal that stimulates the silent D-Box sequence of Aurora-A. EMBO Rep. 2002, 3: 1209-1214. 10.1093/embo-reports/kvf241.PubMed CentralView ArticlePubMedGoogle Scholar
- Arlot-Bonnemains Y, Klotzbucher A, Giet R, Uzbekov R, Bihan R, Prigent C: Identification of a functional destruction box in the Xenopus laevis aurora-A kinase pEg2. FEBS Lett. 2001, 508: 149-152. 10.1016/S0014-5793(01)03048-4.View ArticlePubMedGoogle Scholar
- Siman-Tov MM, Ivens AC, Jaffe CL: Identification and cloning of Lmairk, a member of the Aurora/Ipl1p protein kinase family, from the human protozoan parasite Leishmania. Biochim Biophys Acta. 2001, 1519: 241-245. 10.1016/S0167-4781(01)00240-8.View ArticlePubMedGoogle Scholar
- Shannon KB, Salmon ED: Chromosome dynamics: new light on Aurora B kinase function. Curr Biol. 2002, 12: R458-R460. 10.1016/S0960-9822(02)00945-4.View ArticlePubMedGoogle Scholar
- Murata-Hori M, Wang YL: The kinase activity of aurora B is required for kinetochore-microtubule interactions during mitosis. Curr Biol. 2002, 12: 894-899. 10.1016/S0960-9822(02)00848-5.View ArticlePubMedGoogle Scholar
- Kallio MJ, McCleland ML, Stukenberg PT, Gorbsky GJ: Inhibition of aurora B kinase blocks chromosome segregation, overrides the spindle checkpoint, and perturbs microtubule dynamics in mitosis. Curr Biol. 2002, 12: 900-905. 10.1016/S0960-9822(02)00887-4.View ArticlePubMedGoogle Scholar
- Frank-Vaillant M, Haccard O, Thibier C, Ozon R, Arlot-Bonnemains Y, Prigent C, Jessus C: Progesterone regulates the accumulation and the activation of Eg2 kinase in Xenopus oocytes. J Cell Sci. 2000, 113 (Pt 7): 1127-1138.Google Scholar
- Romano A, Guse A, Krascenicova I, Schnabel H, Schnabel R, Glotzer M: CSC-1: a subunit of the Aurora B kinase complex that binds to the survivin-like protein BIR-1 and the incenp-like protein ICP-1. J Cell Biol. 2003, 161: 229-236. 10.1083/jcb.200207117.PubMed CentralView ArticlePubMedGoogle Scholar
- Adams Jerry, Huang Pearl, Patrick Denis: A strategy for the design of multiplex inhibitors for kinase-mediated signalling in angiogenesis. Current Opinion in Chemical Biology. 2002, 6: 486-492. 10.1016/S1367-5931(02)00357-5.View ArticlePubMedGoogle Scholar
- Fischer OM, Streit S, Hart S, Ullrich A: Beyond Herceptin and Gleevec. Curr Opin Chem Biol. 2003, 7: 490-495. 10.1016/S1367-5931(03)00082-6.View ArticlePubMedGoogle Scholar
- Capdeville R, Buchdunger E, Zimmermann J, Matter A: Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov. 2002, 1: 493-502. 10.1038/nrd839.View ArticlePubMedGoogle Scholar
- Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22: 4673-4680.PubMed CentralView ArticlePubMedGoogle Scholar
- Felsentein J: PHYLIP (Phylogenetic Inference Package). 2000, Seattle, Department of Genetics, University of WashingtonGoogle Scholar
- Strimmer K, von Haesler A: Quartet puzzling: a quartet maximum likelihood method for reconstructing tree topologies. Mol Biol Evol. 1996, 13: 964-969.View ArticleGoogle Scholar
- Swofford DL: PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods). 1999, Sunderland, Massachusetts, Sinauer AssociatesGoogle Scholar
- Huelsenbeck JP, Ronquist F: MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics. 2001, 17: 754-755. 10.1093/bioinformatics/17.8.754.View ArticlePubMedGoogle Scholar
- Ronquist F, Huelsenbeck JP: MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics. 2003, 19: 1572-1574. 10.1093/bioinformatics/btg180.View ArticlePubMedGoogle Scholar
- Page RD: TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci. 1996, 12: 357-358.PubMedGoogle Scholar
- Guex N, Peitsch MC: SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997, 18: 2714-2723.View ArticlePubMedGoogle Scholar
- Liang J, Edelsbrunner H, Woodward C: Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design. Protein Sci. 1998, 7: 1884-1897.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.